Givaudan Net Profit Rises Despite Drop in Sales
By Adria Calatayud
Givaudan reported a rise in net profit for last year, thanks to cost controls that allowed it to increase profitability and offset a drop in sales.
Net profit for 2023 was 893 million Swiss francs ($1.04 billion) compared with CHF856 million a year before, the Swiss supplier of chemicals to the food and cosmetics industries said Thursday.
Sales fell to CHF6.915 billion from CHF7.12 billion, dragged by a decline in the company's taste-and-wellbeing segment, it said. For the fourth quarter alone, sales fell 0.5% to CHF1.65 billion.
Full-year earnings before interest, taxes, depreciation and amortization inched lower to CHF1.47 billion from CHF1.48 billion, but Givaudan's Ebitda margin improved to 21.3% from 20.7%, which it attributed to cost management across the business and a performance-improvement program.
Analysts expected Givaudan's 2023 net profit, Ebitda and sales at CHF842 million, CHF1.47 billion and CHF6.92 billion, respectively, according to consensus estimates provided by the company.
The company said it is on track for its 2025 targets, which include average annual organic sales growth of 4% to 5% over a five-year period.
It intends to propose a dividend of CHF68 a share for 2023, up 1.5% on year.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
January 25, 2024 01:23 ET (06:23 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks